Dronabinol Oral Solution

DRUG2 trials

Sponsors

INSYS Therapeutics Inc, Benuvia Therapeutics Inc.

Conditions

Agitation in DementiaBioavailability

Phase 1

Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions

CompletedNCT01448772

INSYS Therapeutics IncBioavailability

Start: 2011-10-31End: 2011-12-31Updated: 2012-03-26

Phase 2

To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease

Not yet recruitingNCT07422311

Benuvia Therapeutics Inc.Agitation in Dementia

Start: 2026-05-01End: 2028-08-01Target: 140Updated: 2026-02-25

Related Papers

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Journal of Clinical Oncology2016-10-099 citations

A single-dose comparative bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Journal of Clinical Oncology2016-10-09

Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Journal of Clinical Oncology2016-05-204 citations

A single-dose comparative bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers.

Journal of Clinical Oncology2016-05-20